USFDA Delegation visits Divi's Laboratories Limited's Unit I at Choutuppal, Telangana, India

Divi's Laboratories Limited has announced that a high-level delegation from the U.S. Food and Drug Administration (USFDA), including Commissioner Dr. Robert M. Califf, India Country Director Dr. Sarah McMullen, and other officials, visited the company's manufacturing facility in Choutuppal, Telangana, India.

The delegation's visit covered a wide range of topics, reflecting the dynamic landscape of the Active Pharmaceutical Ingredient (API) industry, the integration of new technologies, sustainable practices in chemistry, raising manufacturing standards, and ensuring the availability of APIs. The company showcased its large-scale world-class production facilities, advanced automated manufacturing capabilities, commitment to innovation, and its crucial role in investing in new technologies to ensure a consistent supply of high-quality APIs.

Divi's Laboratories Limited is a globally recognized pharmaceutical manufacturing company known for its commitment to quality and large-scale manufacturing. With a global presence in supplying APIs to more than 100 countries, the company's unwavering commitment to compliance and sustainability sets it apart in the pharmaceutical industry.

"We are proud to participate in this important visit to share our role as a reliable API manufacturer that can deliver large quantities in a relatively short me," stated Dr. Kiran S Divi, CEO of Divi's Laboratories Limited. "We look forward to continuing to engage and be a part of addressing critical issues that affect the worldwide pharmaceutical industry."

Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 3730.05 as compared to the previous close of Rs. 3706.40. The total number of shares traded during the day was 6501 in over 1425 trades.

The stock hit an intraday high of Rs. 3736.90 and intraday low of 3675.25. The net turnover during the day was Rs. 24154684.00.

Source : Equity Bulls

Keywords

DivisLaboratories INE361B01024 Pharmaceuticals USFDA Delegation Choutuppal Telangana India